Kristopher Kuchenbecker
Inotek Pharmaceuticals (United States)(US)Sunesis (United States)(US)
Publications by Year
Research Areas
Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, Epigenetics and DNA Methylation, Occupational and environmental lung diseases, RNA modifications and cancer
Most-Cited Works
- → Chromodomain-Mediated Oligomerization of HP1 Suggests a Nucleosome-Bridging Mechanism for Heterochromatin Assembly(2011)331 cited
- → The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals(2013)162 cited
- → Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism(2015)122 cited
- → The signaling phospholipid PIP 3 creates a new interaction surface on the nuclear receptor SF-1(2014)98 cited
- → Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma(2006)92 cited
- → Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines(2006)66 cited
- → Inhibition of Hsp90 Leads to Cell Cycle Arrest and Apoptosis in Human Malignant Pleural Mesothelioma(2008)57 cited
- → Wnt Inhibitory Factor-1 Gene Transfer Inhibits Melanoma Cell Growth(2007)57 cited
- → Inhibition of Wnt‐2 and galectin‐3 synergistically destabilizes β‐catenin and induces apoptosis in human colorectal cancer cells(2007)54 cited
- → Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer(2013)48 cited